Evidence map›Paper›PMID 40778384›Full record

ReviewFrontiers in digital health2025

Artificial intelligence in personalized rehabilitation: current applications and a SWOT analysis.

Elpidio Attoh-Mensah, Arnaud Boujut, Mikaël Desmons, Anaick Perrochon

Abstract readReview
In one paragraph

Review in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elpidio Attoh-MensahUniversity of Limoges, HAVAE UR 20217, Limoges, France.
Arnaud BoujutUniversity of Limoges, HAVAE UR 20217, Limoges, France.
Mikaël DesmonsUniversity of Limoges, HAVAE UR 20217, Limoges, France.
Anaick PerrochonUniversity of Limoges, HAVAE UR 20217, Limoges, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is transforming personalized rehabilitation by introducing innovative methods to enhance care across diverse medical specialties. Despite its potential, widespread implementation remains limited, largely due to a lack of comprehensive analyses on its benefits and barriers. This mini narrative review examines current applications of AI in personalized rehabilitation and provide a SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis AI is already being used to develop personalized treatment plans, support ongoing patient management, and adapt therapy sessions in real-time. One of its key strengths is the capacity to process vast datasets and monitor real-time information, thereby elevating the level of personalization. Automation of certain tasks can reduce human error and alleviate clinician workload, allowing more time for direct patient care. Opportunities for AI lie in leveraging rapidly advancing technologies to meet the rising demand for rehabilitation services, particularly with aging populations. Collaborations with industry can accelerate innovation, while data sharing can promote best practices across institutions. However, notable challenges persist. High implementation costs, ethical concerns such as algorithmic bias, and risks of increasing healthcare disparities remain major barriers. Additionally, threats such as data privacy breaches and security vulnerabilities emphasize the need for robust, balanced regulatory frameworks. In conclusion, AI holds immense promise for transforming personalized rehabilitation. While current applications are largely in early stages or proof-of-concept phases, ongoing research, ethical foresight, and strategic collaboration are essential to maximize benefits and minimize risks for optimal patient outcomes.

Indexed as

artificial intelligencehealthcarepatient-centered approachpersonalizationrehabilitationSWOT

Identifiers

PMID40778384
PMCPMC12328449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.